PharmaStem Therapeutics, Inc. is the pioneer in the development of umbilical cord and placental blood preservation for therapeutic use.

PharmaStem Therapeutics, Inc. is committed to promoting research & development of new therapies using umbilical cord and placental blood stem cells. The Company licenses its technology to a large number of cord blood banks to assure the widest availability of its life saving discovery.

Why take a risk with something so precious? Patients and obstetricians now have a wide selection of LICENSED banks to choose from.

April 4, 2007
Pharmastem Patents Confirmed After Reexamination by Patent Office

January 5, 2007
U.S. Patent Office Reaffirms Pharmastem Patent

February 10, 2006
PharmaStem Therapeutics Announces Patent License Agreement with Lifebank Corp.

May 9, 2005
US Patent Office Denies Third Party Reexamination Request of Key PharmaStem Patent Claims

April 20, 2005
Pharmastem Enters Into A Patent License Agreement With The University Of Texas M. D. Anderson Cancer Center